Treatment of patients with Langerhans cell histiocytosis with vindesine.
M
M
Hirose
K
K
Ishimoto
T
T
Ninomiya
Y
Y
Kuroda
D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use; D006646:Histiocytosis, Langerhans-Cell / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D007376:Interleukin-2 / Q000627:therapeutic use; D007694:Killer Cells, Natural / Q000276:immunology; D008297:Male; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D014751:Vindesine / Q000627:therapeutic use*
D000972:Antineoplastic Agents, Phytogenic; D007376:Interleukin-2; D014751:Vindesine